CPT® Code 90721

1. Indications

The DTaP/Hib vaccine (CPT® Code 90721) is indicated for the prevention of several serious bacterial infections. The specific indications include:

• Diphtheria: A serious bacterial infection affecting the mucous membranes of the throat and nose, which can lead to breathing difficulties, heart failure, and even death.
• Tetanus: A potentially fatal disease caused by a toxin produced by the bacterium Clostridium tetani, leading to muscle stiffness and spasms.
• Acellular Pertussis: A highly contagious respiratory disease caused by Bordetella pertussis, characterized by severe coughing fits that can lead to complications, especially in infants.
• Haemophilus influenzae type b (Hib): A bacterium that can cause severe infections, particularly in young children, including meningitis, pneumonia, and epiglottitis.

2. Procedure

The administration of the DTaP/Hib vaccine involves several key procedural steps:

• Step 1: Preparation of the vaccine involves ensuring that the vaccine is stored correctly and is at the appropriate temperature for administration. The healthcare provider must check the expiration date and inspect the vial for any particulate matter or discoloration.
• Step 2: The healthcare provider will select an appropriate site for intramuscular injection, typically the anterolateral thigh for infants and the deltoid muscle for older children and adults. The site is cleaned with an antiseptic wipe to reduce the risk of infection.
• Step 3: Using a sterile syringe and needle, the provider will draw the correct dosage of the vaccine from the vial. It is essential to expel any air bubbles from the syringe to ensure accurate dosing.
• Step 4: The needle is then inserted into the muscle at the selected site at a 90-degree angle, and the vaccine is injected slowly and steadily. After the injection, the needle is withdrawn quickly, and gentle pressure is applied to the injection site with a cotton ball or gauze.
• Step 5: The provider will document the administration of the vaccine in the patient's medical record, including the date, vaccine type, lot number, and the site of administration. This documentation is crucial for tracking immunization history and ensuring compliance with vaccination schedules.

3. Post-Procedure

After the administration of the DTaP/Hib vaccine, patients may experience mild side effects, which are typically self-limiting. Common post-procedure care includes monitoring the patient for any immediate allergic reactions, which may occur within minutes of vaccination. Patients should be advised to observe the injection site for signs of redness, swelling, or tenderness. Over-the-counter pain relievers may be recommended to alleviate any discomfort. It is also important to inform patients or guardians about the expected side effects and when to seek medical attention, particularly if there are signs of a severe allergic reaction or if symptoms persist beyond a few days. Follow-up appointments should be scheduled according to the recommended immunization schedule to ensure complete vaccination coverage.